Regenerative medicines are an emerging field of medical science aimed at regeneration, repair, or replacement of damaged tissue and organs. As per the U.S. National Institute of Health, regenerative medicine is the procedure of creating functional tissues to repair and/or replace nonfunctional organs or tissues. With regenerative medicines, tissues or organs that have lost their functioning power due to congenital defects, age, and external or internal damage are repaired or replaced. Some of the application areas of regenerative medicines are neurology, cardiovascular, orthopedic, and musculoskeletal disorders.
Factors such as technological advancements in stem cell therapy and tissue engineering are predicted to propel the global regenerative medicine market during the forecast period. However, ethical issues, post-implantation infections and complications, and regulatory constraints are expected to hamper the growth of the global regenerative medicine market in the years to come. Leading players are focusing on capturing the untapped market to increase their share in the global market. The high number of mergers, acquisitions, and partnerships expected to occur in the coming years is predicted to make the global regenerative medicine market highly competitive in the near future.
Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=419
The global regenerative medicine market is segmented on the basis of technology, application, and geography. Based on geography, the global regenerative medicine market is divided into Asia Pacific, Europe, North America, and Rest of the World. In 2012, the global regenerative medicine market was dominated by North America due to the rising demand for bone and joint reconstructive surgeries. The region’s increasing aging population is predicted to propel the Europe regenerative medicine market in the next few years. Going forward, Asia Pacific is expected to register considerable growth in the global regenerative medicine market.
Companies such as DePuy Synthes, Inc. (HEALOS Bone Graft), Stryker Corporation (Vitoss Bone Graft Substitute), Zimmer Holdings, Inc. (CopiOs Bone Void Filler), and Medtronic, Inc. (INFUSE Bone Graft) are expected to lead the global regenerative medicine market in the years to come. The entry of new players is predicted to create new growth opportunities in the near future.
By technology, the global regenerative medicine market is classified into stem cell therapy, tissue engineering, and biomaterials. In 2012, the biomaterials segment dominated the global regenerative medicine market due to factors such as favorable reimbursement policies. Moreover, strong demand for biomaterials is predicted to propel the segment in the coming few years.
Key Segments of Global Regenerative Medicine Market
Regenerative Medicine (Bone and Joint) Market, by Technology
- Stem Cell Therapy
- Tissue Engineering
Regenerative Medicine (Bone and Joint) Market, by Application
- Bone Graft Substitutes
- Osteoarticular Diseases
- Allogeneic Bones
- Autogenic Bones
Regenerative Medicine (Bone and Joint) Market, by Geography
- North America
- Rest of the World
Transparency Market Research
90 State Street,
NY - 12207
USA - Canada Toll Free 866-552-3453
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.